Kaleido Stock Valuation

KLDO -  USA Stock  

USD 2.19  0.06  2.67%

What is the current enterprise value of Kaleido Biosciences? Calculating the true value of any business is not as easy as it may seem. While the market cap of a public entity, such as Kaleido Biosciences, is its stock price multiplied by the total number of shares outstanding, calculating Kaleido Biosciences' enterprise value requires a different approach. It uses Kaleido Biosciences' balance sheet items such as long-term debt, the book value of the preferred stock, minority interest, and other important financials.
Tangible Asset Value is expected to rise to about 73.2 M this year, although the value of Free Cash Flow will most likely fall to (63.6 M).
Kaleido Biosciences secures a last-minute Real Value of $5.08 per share. The latest price of the firm is $2.19. Based on Macroaxis valuation methodology, the firm appears to be undervalued. Our model forecasts the value of Kaleido Biosciences from analyzing the firm fundamentals such as Shares Owned by Insiders of 4.71 %, current valuation of 76.6 M, and Return On Equity of (276.59) % as well as examining its technical indicators and Probability Of Bankruptcy. In general, we recommend picking up undervalued stocks and discarding overvalued stocks since, at some point, asset prices and their ongoing real values will merge together.

Kaleido Valuation 

Kaleido Biosciences Valuation Module provides a unique way to ballpark how much the company is worth today. It is done using both, our quantitative analysis of the company fundamentals as well as its intrinsic market price estimation to project the real value. We also take into consideration other essential factors such as Kaleido Biosciences's management style, its c-level domain expertise and tenure, its overall leadership history as well as current capital structure, and future earnings potential.
21st of January 2022
Please note that Kaleido Biosciences' price fluctuation is relatively risky at this time. Calculation of the real value of Kaleido Biosciences is based on 3 months time horizon. Increasing Kaleido Biosciences' time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Our valuation method for Kaleido Biosciences is useful when determining the fair value of the Kaleido stock, which is usually determined by what a typical buyer is willing to pay for full or partial control of Kaleido Biosciences. Since Kaleido Biosciences is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Kaleido Stock. However, Kaleido Biosciences' intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value.
Real Value
Estimating the potential upside or downside of Kaleido Biosciences helps investors to forecast how Kaleido stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Kaleido Biosciences more accurately as focusing exclusively on Kaleido Biosciences' fundamentals will not take into account other important factors:
Estimates (4)
LowProjected EPSHigh
LowEstimated ValueHigh
5 Analysts
LowTarget PriceHigh
Traditionally analysts and sophisticated investors use multiple methods for valuing a cash-flow-generating entity or its stock. For example, some money managers use Kaleido Biosciences' intrinsic value based on its ongoing forecasts of Kaleido Biosciences' financial statements. In contrast, other private, professional wealth advisors use a multiplier approach by looking to relative value analysis against Kaleido Biosciences' closest peers. When choosing an evaluation method for Kaleido Biosciences, ensure it is appropriate for the firm given its current financial situation and market classification. If more than one evaluation category is relevant, we suggest using both methods to arrive at a better estimate.

Kaleido Valuation Drivers Correlation

Many accounts on the financial statements of Kaleido Biosciences are highly interrelated and sometimes correlated. Consequently, when conducting Kaleido's valuation analysis, one should examine all of the accounts reported to obtain a complete picture of its financial situation. We provide a unique feature to present a conventional correlation table purposely composed against different valuation-related drivers of Kaleido
Click cells to compare fundamentals

Kaleido Valuation Trend

Knowing Kaleido Biosciences' actual value is paramount for traders to make sound investment determinations. Kaleido Biosciences' real value is not only important for the investor to make better decisions but also for a more accurate overall view of Kaleido Biosciences' financial worth over time since having this information enables investors and analysts to forecast the earnings more efficiently. Using both Kaleido Biosciences' enterprise value as well as its market capitalization is the best way to gauging the value of the company and is usually enough for investors to make market timing descisions.

Kaleido Market Cap

Kaleido Biosciences is currently regarded as number one stock in market capitalization category among related companies. Market capitalization of Biotechnology industry is now estimated at about 118.07 Million. Kaleido Biosciences totals roughly 94.13 Million in market capitalization claiming about 80% of stocks in Biotechnology industry.
Capitalization  Valuation  Total debt  Revenue  Workforce

Kaleido Biosciences Valuation Ratios as Compared to Competition

Comparative valuation techniques use various fundamental indicators to help in determining Kaleido Biosciences's current stock value. Our valuation model uses many indicators to compare Kaleido Biosciences value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Kaleido Biosciences competition to find correlations between indicators driving Kaleido Biosciences's intrinsic value. More Info.
Kaleido Biosciences is currently regarded as number one stock in price to earning category among related companies. It is rated second overall in beta category among related companies . . Comparative valuation analysis is a catch-all model that can be used if you cannot value Kaleido Biosciences by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Kaleido Biosciences' Stock . Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Kaleido Biosciences' earnings, one of the primary drivers of an investment's value.

About Kaleido Biosciences Valuation

The equity valuation mechanism determines the current worth of Kaleido Biosciences on a weekly basis. We use both absolute as well as relative valuation methodologies to arrive at the intrinsic value of Kaleido Biosciences. In general, an absolute valuation paradigm, as applied to this company, attempts to find the value of Kaleido Biosciences based exclusively on its fundamental and basic technical indicators. By analyzing Kaleido Biosciences's financials, quarterly and monthly indicators, and its related drivers such as dividends, operating cash flow, and various types of growth rates, we attempt to find the most accurate representation of Kaleido Biosciences's intrinsic value. In some cases, mostly for established, large-cap companies, we also incorporate more traditional valuation methods such as dividend discount, discounted cash flow, or asset-based models. As compared to an absolute model, our relative valuation model uses a comparative analysis of Kaleido Biosciences. We calculate exposure to Kaleido Biosciences's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to Kaleido Biosciences's related companies.
Last ReportedProjected for 2022
Gross Profit877.5 K872.4 K
Profit Margin(75.34) (81.29) 
Kaleido Biosciences, Inc., a clinical-stage healthcare company, develops microbiome metabolic therapies. The company was incorporated in 2015 and is headquartered in Lexington, Massachusetts. Kaleido Biosciences operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 82 people.

Kaleido Biosciences Quarterly Enterprise Value

179.68 MillionShare

Kaleido Biosciences Valuation Growth Rates

Growth stocks usually refer to those companies expected to grow sales and earnings faster than the market average. Growth stocks typically don't pay dividends, often look expensive, and usually trading at a high P/E ratio. Nevertheless, such valuations could be relatively cheap if the company continues to grow, which will drive the share price up. However, since most investors are paying a high price for a growth stock, based on expectations, if those expectations are not fully realized, growth stocks can see dramatic declines. Note, investing in growth stocks can be very risky. If the company such as Kaleido Biosciences does not do well, investors take a loss on the stock when it is time to sell. Also, because growth stocks typically do not pay dividends, the only opportunity an investor has to make money on their investment is when they eventually sell their shares.
Quick Ratio2.89
Enterprise Value To Ebitda-0.90
Enterprise Value To Revenue89.60

Kaleido Biosciences Current Valuation Indicators

Valuation refers to the process of determining the present value of Kaleido Biosciences and all of its assets. It can be calculated using a number of techniques. As many analysts who try to value Kaleido we look at many different elements of the entity such as Kaleido's management, its prospective future earnings, the current market value of the company's assets, as well as its capital structure formation.
Valuations are an essential part of business, for companies themselves, but also for investors. For companies, such as Kaleido Biosciences, valuations can help measure their progress and success and can help them track their performance in the market compared to others. In addition, investors can use Kaleido Biosciences' valuations to help determine the worth of potential investments. They can do this by using data and information made public by a company. Regardless of who the valuation is for, it essentially describes Kaleido Biosciences' worth.
Please see Stocks Correlation. Note that the Kaleido Biosciences information on this page should be used as a complementary analysis to other Kaleido Biosciences' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Bond Analysis module to evaluate and analyze corporate bonds as a potential investment for your portfolios..

Complementary Tools for Kaleido Stock analysis

When running Kaleido Biosciences price analysis, check to measure Kaleido Biosciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Kaleido Biosciences is operating at the current time. Most of Kaleido Biosciences' value examination focuses on studying past and present price action to predict the probability of Kaleido Biosciences' future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Kaleido Biosciences' price. Additionally, you may evaluate how the addition of Kaleido Biosciences to your portfolios can decrease your overall portfolio volatility.
Watchlist Optimization
Optimize watchlists to build efficient portfolio or rebalance existing positions based on mean-variance optimization algorithm
Positions Ratings
Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance
Price Transformation
Use Price Transformation models to analyze depth of different equity instruments across global markets
Global Markets Map
Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes
Commodity Channel Index
Use Commodity Channel Index to analyze current equity momentum
Is Kaleido Biosciences' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Kaleido Biosciences. If investors know Kaleido will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Kaleido Biosciences listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Kaleido Biosciences is measured differently than its book value, which is the value of Kaleido that is recorded on the company's balance sheet. Investors also form their own opinion of Kaleido Biosciences' value that differs from its market value or its book value, called intrinsic value, which is Kaleido Biosciences' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Kaleido Biosciences' market value can be influenced by many factors that don't directly affect Kaleido Biosciences' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Kaleido Biosciences' value and its price as these two are different measures arrived at by different means. Investors typically determine Kaleido Biosciences value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Kaleido Biosciences' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.